Browsing the "Fidelity Biosciences" Tag →

02 2015 March
By FinSMEs
0 Comments

Mersana Therapeutics Raises $35M in Series B-1 Financing

Mersana Therapeutics, Inc., a Cambridgre, MA-based drug developer, raised $35m in Series B-1 financing. The round was led by existing...

Read More →
18 2015 February
By FinSMEs
0 Comments

TraceLink Raises $20M in Venture Funding

TraceLink Inc., a Wakefield, MA-based provider of solutions for Life Sciences companies to protect patients From counterfeit drugs, raised $20m...

Read More →
26 2015 January
By FinSMEs
0 Comments

Iora Health Raises $28M in Series C Funding

Iora Health, a Cambridge, Massachusetts-based healthcare company, raised $28m in Series C funding. Backers included Foundation Medical Partners, Rice Management...

Read More →
22 2015 January
By FinSMEs
0 Comments

Innovent Biologics Raises $100M in Series C Financing

Innovent Biologics, Inc., a Shangai, China-based biopharmaceutical company, raised $100m in Series C financing. The round was led by Legend...

Read More →
21 2015 January
By FinSMEs
0 Comments

Regenxbio Closes $30M in Series C Funding

Regenxbio, a Washington, DC-based gene therapy biotech company, closed $30m in Series C funding. The round was led by Venrock...

Read More →
08 2015 January
By FinSMEs
0 Comments

Surface Oncology Closes $35M Series A Funding Round

Surface Oncology, a Cambridge, Mass.-based company developing cancer immunotherapies, closed a $35m Series A funding round. Backers included The Atlas...

Read More →
09 2014 December
By FinSMEs
0 Comments

Adagene Raises $8M in Series A Funding

Adagene, a Suzhou Industrial Park, China-based biotech company, raised $8m in Series A funding. Backers included Fidelity Biosciences, Fidelity Asia...

Read More →
19 2014 November
By FinSMEs
0 Comments

Novaerus Completes $10M Funding Round

Novaerus, a Chicago, IL- and Dublin, Ireland-based company that applies plasma-based, airborne pathogen control technology to improve the business and quality...

Read More →
12 2014 November
By FinSMEs
0 Comments

Blueprint Medicines Completes $50M Series C Financing

Blueprint Medicines, a Cambridge, MA-based developer of selective kinase inhibitors for genomically defined cancers, completed a $50m Series C financing....

Read More →
21 2014 October
By FinSMEs
0 Comments

Unum Therapeutics Raises $12M in Series A Funding

Unum Therapeutics, a Cambridge, MA-based company developing cellular immunotherapy to treat cancer, raised $12m in Series A funding. The round...

Read More →
02 2014 October
By FinSMEs
0 Comments

Aclaris Therapeutics Closes $21M Series B Financing

Aclaris Therapeutics, Inc., a Malvern, Pennsylvania-based specialty pharmaceutical company, closed on a $21m Series B financing. Backers included existing investors...

Read More →
25 2014 September
By FinSMEs
0 Comments

Adaptimmune Raises $104m in Venture Capital

Adaptimmune, an Oxford, UK-based biotechnology company, raised $104m in venture capital. The round was led by New Enterprise Associates with...

Read More →
23 2014 June
By FinSMEs
0 Comments

Dimension Therapeutics Closes $30M Financing

Dimension Therapeutics, a Cambridge, MA-based gene therapy company focused on developing novel treatments for rare diseases, closed a $30m financing....

Read More →
19 2014 May
By FinSMEs
0 Comments

Coherus BioSciences Closes $55M Series C Financing

Coherus BioSciences, Inc., a San Francisco, CA-based biologics platform company focused on biosimilars, closed a $55m Series C financing. New...

Read More →